Human macrophages have been implicated in connective tissue remodeling, however, little is known about their direct effects upon collagen degradation. We now report that human alveolar macrophages in culture produced both a collagenase and a collagenase inhibitor. The collagenase was secreted in latent form and could be activated by exposure to trypsin. Collagenase production could be increased three-to fourfold by incubating the cells with lipopolysaccharide, but synthesis was largely unaffected by exposure to phorbol myristate acetate. By several criteria, macrophage collagenase was the same as the collagenase secreted by human skin fibroblasts: (a) they were antigenically indistinguishable in double immunodiffusion; (b) both degraded type III collagen preferentially to type I, had little activity against type II collagen, and none against types IV and V, and (c) their affinity for susceptible collagens was equivalent, Michaelis constant = 1-2 MM. Collagenase inhibitory activity was also present in the macrophage-conditioned medium, and was accounted for by an antigen that showed immunologic and functional identity with the collagenase inhibitor secreted by human skin fibroblasts. The amount of inhibitor released by unstimulated cells, -100 ng/106 cells per 24 h, was substantially augmented by both phorbol and lipopolysaccharide, although considerable variability in response to these agents was observed between macrophage populations derived from different subjects. As negligible quantities of collagenase or collagenase inhibitor were detectable intracellularly, it appeared that both proteins were secreted rapidly after synthesis. Thus, human macrophages have the capacity to modulate collagen degradation directly by production of collagenase and collagenase inhibitor.
Introduction
Collagenase catalyzes the initial and rate-limiting step of collagen degradation (1) (2) (3) . Accordingly, collagenases occupy a crucial position in normal collagen turnover and the maintenance of proper connective tissue architecture. Elevated collagenase activity has been associated with disorders such as rheumatoid arthritis (4) Receivedfor publication 31 December 1984. malian connective tissue cells (6) (7) (8) (9) (10) and inflammatory cells (11) (12) (13) (14) (15) , including macrophages. A collagenase secreted by human skin fibroblasts has been purified to homogeneity (7) , biochemically characterized (16) , and studied in regard to enzyme kinetics (2, 3, 17) , biosynthesis (18) , and mechanisms of activation (19) . Human skin fibroblasts also secrete a collagenase inhibitor of Mr 28 ,500 (20, 21) (13) .
We now report that human alveolar macrophages in culture produce collagenase and collagenase inhibitor that are immunologically and functionally identical to the collagenase and collagenase inhibitor elaborated by human skin fibroblasts.
Lipopolysaccharide (LPS)' leads to a substantial increase in collagenase production, which is often accompanied by a parallel elevation in collagenase inhibitor secretion, whereas phorbol myristate acetate (PMA) appears to selectively stimulate inhibitor biosynthesis, with little or no change in collagenase production. These findings indicate that macrophages may directly influence the turnover of collagen at sites of inflammation. Cell-conditioned medium. Conditioned medium was removed every 24 h and replaced with fresh medium. After its removal, the conditioned medium was adjusted to 0.05 M Tris, 0.01 M CaCl2, pH 7.5. For certain studies of functional collagenase or inhibitor activity, conditioned medium was dialyzed overnight against 0.005 M Tris, 0.001 M CaC12, pH 7.5, then lyophilized and resuspended in water to achieve a 10-fold concentration.
Methods
Purification of human skin Jfbroblast collagenase and collagenase inhibitor. Both collagenase and collagenase inhibitor were purified to homogeneity from the serum-containing medium of confluent normal human skin fibroblast cultures as described previously (7, 20 To determine collagenase inhibitor activity, concentrated macrophage medium was treated with EDTA (20 mM) to destroy any intrinsic enzyme, exhaustively dialyzed, and then assayed for capacity to inhibit pure fibroblast collagenase (7, 21 (21) were performed upon cell-conditioned medium and cell extracts. Extracts were prepared by scraping the cell layer into 1 ml of buffer (0.05 M Tris, 0.01 M CaCl2, pH 7.5), followed by sonication and centrifugation (2,500 g for 20 min). Gel diffusion was performed in 1.0% Ionagar (28) .
Metabolic labeling and immunoprecipitation of collagenase and collagenase inhibitor. The metabolic labeling and immunoprecipitation procedures for collagenase and collagenase inhibitor were the same, except the former utilized labeling with [35SJmethionine (New England Nuclear, Boston, MA), and the latter [35Slcysteine (New England Nuclear). Macrophages were exposed to methionine-free or cysteinefree medium containing the appropriate labeled amino acid (50-100 ,MCi/ml of medium) for 24 h. 150 Ml of pulsed medium was then incubated with 5 Ml of either specific or preimmune antibody at 4°C overnight in a total reaction volume of 300 Ml (buffer = 0.04 M sodium phosphate, pH 8.0, containing 0.15 M NaCl, 0.1% Triton X-100, 1 mM PMSF). To precipitate the labeled protein, IgGsorb (The Enzyme Center, Inc., Malden, MA) was added for I h at 4°C, after which the immunoprecipitates were washed extensively, and then dissolved in 100 Ml of sample buffer containing 0.0625 M Tris-HCl (pH 6.8), 8 M urea, and 3% sodium dodecyl sulfate. After boiling, the samples were subjected to polyacrylamide gel electrophoresis (29) , the slab gels equilibrated with En3Hance (New England Nuclear) for 1.5 h, rinsed in cold distilled water for 1 h, and then dried under vacuum. The dried gels were exposed to Kodak XAR-5 X-Omat AR film (Eastman Kodak Co., Rochester, NY) at -70'C (30) .
Other assays. Protein concentrations were determined spectrophotometrically by the method of Groves et al. (31) with bovine serum albumin as a standard. Collagen content was determined by hydroxyproline assay (32).
Results
Collagenase. Alveolar macrophages were obtained from three volunteer smokers by saline bronchoalveolar lavage and placed in culture as described under Methods. Unconcentrated conditioned medium derived from the macrophages of one such individual, which was collected between 24 and 48 h of incubation, possessed significant collagenolytic activity ( Fig. 1  A, Macrophage-conditioned medium, derived from cells of the same individual which produced measurable collagenolytic activity (J.M.), was then subjected to the ELISA for fibroblast collagenase. As shown in Fig. 1 (Fig. 2) . Furthermore, this antibody abolished all the type I collagenolytic activity present in macrophage medium (not shown).
The immunologic identity of macrophage-derived collagenase to human fibroblast collagenase was used to examine enzyme production in macrophage-conditioned medium obtained from cells of the two individuals (D.S. and L.W.) which failed to elaborate demonstrable collagenolytic activity. Em- (20) . Collagenase: F, pure fibroblast collagenase; M, macrophage medium; antibody to fibroblast collagenase is contained in the center well. Inhibitor: F, pure fibroblast collagenase inhibitor; M, macrophage medium; antibody to fibroblast inhibitor is contained in the center well.
ploying the ELISA for fibroblast collagenase, medium from the unstimulated cells of one patient (D.S.) contained measurable quantities of immunoreactive protein. Cells from both patients responded to exposure to LPS with a significant increase in immunoreactive material released into culture medium, whereas exposure to phorbol produced little or no effect ( Fig. 1 B, D. S., L.W.). The stimulation of collagenase production by LPS reflected an increase in the synthesis of new enzyme protein, as demonstrated by biosynthetic labeling with [35S~methionine and subsequent immunoprecipitation using specific collagenase antibody (Fig. 3) . Under any tested condition, however, collagenase activity in medium conditioned by these two subjects' cells could not be detected due to the presence of a molar excess of a collagenase inhibitor simultaneously secreted by such macrophages (Fig. 1 C, D. S., L.W., see below).
Collagenase inhibitor. The same conditioned media examined for collagenase activity and immunoreactivity was tested in an ELISA using antibody to human fibroblast collagenase inhibitor (21) . Macrophage-conditioned medium from the unstimulated cells of all three individuals contained an amount of immunoreactive material approximating 100 ng/ 106 cells per 24 h (Fig. 1 C) . Expression of inhibitor was stimulated in the cells of two subjects (D.S., L.W.) two-to fourfold by exposure to LPS, while PMA produced a fourfold enhancement in inhibitor levels ( Fig. 1 C, (Fig. 3) . Macrophages derived from the third individual (J.M.) were not stimulated by either LPS or PMA to produce increased quantities of inhibitor ( Fig. 1 C, J.M.) . To further characterize this immunoreactivity, medium was concentrated and examined by double immunodiffusion. A line of complete identity was observed between the macrophage medium and pure fibroblast collagenase inhibitor using antibody directed against the fibroblast protein (Fig. 2) . The functional identity of the immunoreactive material was established by its inhibition of fibroblast collagenase activity. Based on the amount of immunoreactive material in concentrated macrophage medium, a 1:1 molar stoichiometry of inhibition was observed with respect to enzyme (Fig. 4) .
To test the hypothesis that macrophage-derived collagenase and collagenase inhibitor are secretory proteins, intracellular vs. extracellular levels of both were compared (Table II) which suggested that their biologic role is to modulate collagen turnover in the extracellular matrix.
Discussion
These studies demonstrate that human alveolar macrophages produce two substances in vitro that directly affect collagen degradation, collagenase, and collagenase inhibitor. The first of these products was an antigen immunologically identical to human skin fibroblast collagenase, the quantity of which paralleled collagenase activity. The catalytic properties of the macrophage-produced enzyme were also very similar to fibroblast collagenase (3), as manifested by its collagen type specificity and affinity (lIKm) for monomeric collagen substrates. Macrophage-conditioned medium also contained collagenase inhibitory activity, reflecting the presence of an antigen immunologically identical to the collagenase inhibitor secreted by human skin fibroblasts. The amount of inhibitor released in unstimulated cultures was -100 ng/ 106 cells per d, as compared with -700 ng/106 cells per d found in confluent skin fibroblast cultures (21) . The inhibitor's functional activity also matched that of its fibroblast-derived counterpart. It should be emphasized that the presence of collagenase inhibitor in culture medium markedly affects observed collagenolytic activity. Indeed, in macrophage-conditioned medium using cells derived from two of the individuals in this study, collagenase was demonstrable only by immunologic techniques (Figs. 1 and 3) ; functional enzyme activity was completely obscured by an excess of collagenase inhibitor concomitantly released into the culture medium. Therefore, immunologic assessments of both enzyme and inhibitor are crucial to adequately understand the potential mechanisms by which macrophages regulate collagen turnover.
As observed with nonhuman macrophages (1 1), LPS produced a severalfold increase in collagenase secretion by human alveolar macrophages. This effect was mediated via the synthesis of new enzyme, as demonstrated by immunoprecipitation of metabolically labeled collagenase (Fig. 3) (Fig. 3) . The data thus suggest that the expression of collagenase and collagenase inhibitor may occur in a coordinate manner in response to an agent such as LPS; yet, another substance such as PMA can clearly enhance inhibitor secretion with little or no effect on collagenase levels (Fig. 1) . Therefore, collagenase and collagenase inhibitor production are not necessarily regulated in tandem and may vary depending upon exposure to specific chemical agents. In any event, both macrophage collagenase and collagenase inhibitor appear to function in a secretory capacity; neither protein is accumulated intracellularly to a significant extent (Table II) .
The collagenase and collagenase inhibitors derived from fibroblasts and macrophages are structurally and functionally distinct from the analogous molecules of human neutrophils (14, 15, 33) . Neutrophil collagenase preferentially cleaves monomeric type I collagen as compared with type III (I/III > 10; [34] ), whereas macrophage-derived collagenase exhibits the opposite specificity (III/I > 10; Table I ). The neutrophil collagenase inhibitor functions via a thiol-disulfide exchange mechanism (33) , while agents such as mersalyl and oxidized glutathione do not affect fibroblast (20) or macrophage inhibitor activity (not shown). Furthermore, neutrophil extracts do not react immunologically with fibroblast collagenase inhibitor (20) . (Fig. 1) .
The role of the macrophage in collagen turnover extends beyond its capacity to secrete collagenase and collagenase inhibitor. Macrophages are a source of mediators such as interleukin-1 and prostaglandins (35) , of structural macromolecules such as fibronectin (36), and of proteinase inhibitors such as a-2-macroglobulin (37), all of which may influence collagen metabolism. Our study indicates, however, that human macrophages have the direct capacity to modulate collagen turnover. The results also indicate an avenue for the study of macrophage-mediated collagenolysis, since sensitive probes are presently available for this collagenolytic system.
